F Nardelli
Overview
Explore the profile of F Nardelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Catena U, Campo R, Bolomini G, Moruzzi M, Verdecchia V, Nardelli F, et al.
Facts Views Vis Obgyn
. 2021 Apr;
13(1):67-71.
PMID: 33889862
T-shaped uterus is a congenital uterine malformation (CUM), only recently defined by the ESGE ESHRE classification as Class U1a. The uterus is characterised by a narrow uterine cavity due to...
2.
Moro F, Bolomini G, Sibal M, Vijayaraghavan S, Venkatesh P, Nardelli F, et al.
Ultrasound Obstet Gynecol
. 2020 Jan;
56(6):934-943.
PMID: 31975482
Objectives: To describe the clinical and ultrasound characteristics of adnexal torsion. Methods: This was a retrospective study. From the operative records of the eight participating gynecological ultrasound centers, we identified...
3.
Knez J, Nardelli F, Van den Bosch T, Sladkevicius P, Valentin L, Jurkovic D
Ultrasound Obstet Gynecol
. 2019 Dec;
56(3):453-459.
PMID: 31875325
Objective: To describe the clinical and ultrasound characteristics of urinary bladder malignancies diagnosed on transvaginal ultrasound in women presenting with suspected gynecological problems. Methods: This was a multicenter retrospective study...
4.
Paissoni C, Nardelli F, Zanella S, Curnis F, Belvisi L, Musco G, et al.
Phys Chem Chem Phys
. 2018 May;
20(23):15807-15816.
PMID: 29845162
Hybrid cyclic α/β-peptides, in which one or more β-amino acids are incorporated into the backbone, are gaining increasing interest as potential therapeutics, thanks to their ability to achieve enhanced binding...
5.
Gueli Alletti S, Petrillo M, Vizzielli G, Bottoni C, Nardelli F, Costantini B, et al.
Gynecol Oncol
. 2016 Oct;
143(3):516-520.
PMID: 27769526
Objective: To further investigate the role of MIS comparing patients submitted to MI-IDS with a balanced population treated by standard laparotomy. Methods: The investigational arm (Cases) includes 30 AEOC patients...
6.
Bellarosa D, Ciucci A, Bullo A, Nardelli F, Manzini S, Maggi C, et al.
J Pharmacol Exp Ther
. 2001 Feb;
296(2):276-83.
PMID: 11160608
Cytotoxic drugs commonly used in cancer therapy promote tumor cell death by inducing apoptosis, but the cell death pathway(s) is likely dependent on the mechanism of drug action. In the...
7.
Palma C, Bigioni M, Irrissuto C, Nardelli F, Maggi C, Manzini S
Br J Cancer
. 2000 Jan;
82(2):480-7.
PMID: 10646908
Astrocytes harbour functional receptors to many neurotransmitters, including substance P (SP), an undecapeptide belonging to the tachykinin family of peptide transmitters. SP activates malignant glial cells to induce cytokine release...
8.
Palma C, Nardelli F, Manzini S
Eur J Pharmacol
. 1999 Jul;
374(3):435-43.
PMID: 10422788
Binding characteristics and functional antagonism exerted by two structurally related tachykinin NK1 receptor antagonists, MEN 11467 ((1R,2S)-2N[1(H)indol-3-yl-carbonyl]-1-N-{Nalpha(p-tolylacetyl+ ++)-Nalpha(methyl)-D-3-(2-naphthyl)alanyl}diaminocyclohexane) and FK888 (N2-[(4R)-4-hydroxy-1-(1-methyl-1H-indol-3-yl)carbonyl-L-prolyl]-N-methy l-N-phenylmethyl-L-3-(2-naphthyl)alaninamide), were investigated in the human astrocytoma cell line...
9.
Palma C, Nardelli F, Manzini S, Maggi C
Br J Cancer
. 1999 Jan;
79(2):236-43.
PMID: 9888463
The neuropeptide substance P (SP), by stimulating tachykinin NK1 receptors (NK1R), triggers a number of biological responses in human glioma cells which are potentially relevant for tumour growth. First, radioligand...
10.
Palma C, Bellarosa D, Nardelli F, Mannori G, Manzini S
Mediators Inflamm
. 1998 Aug;
7(3):211-5.
PMID: 9705609
On human endothelial cells from umbilical cord (HUVEC) are present, in addition to E- and P-selectins, their cognate ligands. Differently from selectins, the ligand expression is constitutive and not modulated...